- Home
- LPSN vs TLPH Comparison
LPSN vs TLPH Comparison
Compare LPSN & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPSN | TLPH |
|---|---|---|
| Founded | 1995 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.5M | 37.9M |
| IPO Year | 2000 | 2010 |
Fundamental Metrics
Financial Performance| Metric | LPSN | TLPH |
|---|---|---|
| Price | $3.00 | $0.89 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 92.8K | ★ 199.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $249,838,000.00 | $2,151,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.39 | $0.38 |
| 52 Week High | $7.54 | $1.57 |
Technical Indicators
Market Signals| Indicator | LPSN | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 49.20 |
| Support Level | $2.94 | $0.86 |
| Resistance Level | $4.23 | $1.03 |
| Average True Range (ATR) | 0.19 | 0.06 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 46.32 | 55.73 |
Price Performance
Historical ComparisonAbout LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.